Skip to main content
Top
Gepubliceerd in:

Open Access 06-09-2024 | Letter to the Editor

Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation

Auteurs: Alwin B. P. Noordman, Alexander H. Maass

Gepubliceerd in: Netherlands Heart Journal | Uitgave 10/2024

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN
Dear editor,
Verheul et al. present their important data from a Dutch registry of patients with idiopathic ventricular fibrillation (iVF) [1]. They underline the importance of comprehensive diagnostic testing to find a specific diagnosis. An underappreciated topic is prediction of future arrhythmic events as 74% of their patients do not experience appropriate ICD therapy. These young patients are prone to complications due to risk of electrode failure and need for multiple future interventions.
We previously demonstrated that secondary prevention patients with an unclear cause of ventricular arrhythmia received significantly less appropriate ICD therapy compared to those with a clear cause (14% vs. 41%). Considering that the rate of first appropriate therapy was highest in the first two years, [2] patients who do not receive appropriate therapy within the lifetime of their first ICD may not derive sufficient benefit to warrant ICD replacement.
We hope that the Dutch iVF registry can provide predictors for future arrhythmic events to optimally advise patients in the difficult decision-making process surrounding ICD replacement [3]. If we can identify patients with low risk of recurrence, ICD implantation may even be omitted altogether.

Funding

There was no funding obtained for this manuscript.

Conflict of interest

A.B.P. Noordman and A.H. Maass declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articleʼs Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleʼs Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

Netherlands Heart Journal

Het Netherlands Heart Journal wordt uitgegeven in samenwerking met de Nederlandse Vereniging voor Cardiologie. Het tijdschrift is Engelstalig en wordt gratis beschikbaa ...

Literatuur
1.
go back to reference Verheul LM, Groeneveld SA, Stoks J, et al. The Dutch idiopathic ventricular fibrillation registry: progress report on the quest to identify the unidentifiable. Neth Heart J. 2024;32:238–44.CrossRefPubMedPubMedCentral Verheul LM, Groeneveld SA, Stoks J, et al. The Dutch idiopathic ventricular fibrillation registry: progress report on the quest to identify the unidentifiable. Neth Heart J. 2024;32:238–44.CrossRefPubMedPubMedCentral
2.
go back to reference Noordman ABP, Rienstra M, Blaauw Y, et al. Appropriate Implantable Cardioverter-Defibrillator therapy in patients with ventricular arrhythmia of unclear cause in secondary prevention of sudden cardiac death. J Clin Med. 2023;12:4479.CrossRefPubMedPubMedCentral Noordman ABP, Rienstra M, Blaauw Y, et al. Appropriate Implantable Cardioverter-Defibrillator therapy in patients with ventricular arrhythmia of unclear cause in secondary prevention of sudden cardiac death. J Clin Med. 2023;12:4479.CrossRefPubMedPubMedCentral
3.
go back to reference Groenveld HF, Coster JE, van Veldhuisen DJ, et al. Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making. Neth Heart J. 2021;29:243–52.CrossRefPubMedPubMedCentral Groenveld HF, Coster JE, van Veldhuisen DJ, et al. Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making. Neth Heart J. 2021;29:243–52.CrossRefPubMedPubMedCentral
Metagegevens
Titel
Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation
Auteurs
Alwin B. P. Noordman
Alexander H. Maass
Publicatiedatum
06-09-2024
Uitgeverij
BSL Media & Learning
Gepubliceerd in
Netherlands Heart Journal / Uitgave 10/2024
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-024-01898-0